Although the increased PKC activity may increase titin-based passive force via phosphorylation of the PEVK segment [81], coupled with reduced PKA-based phosphorylation of the N2B segment [e.g., 49–51], it is reasonable to consider that the overall titin-based passive force decreases in DCM. The gene discussed is PRRT2; the disease is familial dilated cardiomyopathy.